IntegraGen, of Paris, appointed Gerard Vaillant nonexecutive director.
Isotechnika Inc., of Edmonton, Alberta, appointed Launa Aspeslet chief operating officer.
Kosan Biosciences Inc., of Hayward, Calif., named Albert Kraus vice president, regulatory affairs.
Linguagen Corp., of Cranbury, N.J., appointed Susan Welsh president.
Martek Biosciences, of Columbia, Md., appointed Polly Kawalek to its board.
MediciNova Inc., of San Diego, appointed Jeff Himawan to its board.
Metabasis Therapeutics Inc., of San Diego, appointed Howard Foyt vice president, clinical development; Wayne Frost vice president, regulatory affairs and quality assurance; and Jeff Jensen senior director, clinical operations.
MicroIslet Inc., of San Diego, appointed James Gavin interim president and CEO.
Millennium Pharmaceuticals Inc., of Cambridge, Mass., appointed Christophe Bianchi executive vice president for commercial operations.
Mpex Pharmaceuticals Inc., of San Diego, appointed Matthew Wikler chief medical officer.
Nabi Biopharmaceuticals, of Boca Raton, Fla., appointed Thomas Rathjen vice president of investor relations.
Neurologix Inc., of Fort Lee, N.J., appointed Marc Panoff chief financial officer and chief accounting officer.
OncoMethylome Sciences, of Durham, N.C., appointed Philip Schein to its board.
Oragenics Inc., of Alachua, Fla., appointed Raman Bedi senior consultant.
OrthoLogic Corp., of Tempe, Ariz., appointed Les Taeger senior vice president and chief financial officer.
Pharmacopeia, of Princeton, N.J., said its president and CEO, Leslie Browne, was appointed to the board of trustees of the Biotechnology Council of New Jersey.
Pharsight Corp., of Mountain View, Calif., appointed William Bachman senior scientific consultant, Andreas Krause senior scientist and John Warner senior scientist in strategic consulting services in the U.S.
Pro-Pharmaceuticals Inc., of Newton, Mass., appointed Anatole Klyosov chief scientist.
pSivida Ltd., of Perth, Australia, appointed Heather Zampatti nonexecutive director.
SciGene, of Sunnyvale, Calif., appointed Tony Galindo director, product manufacturing.
SGX Pharmaceuticals Inc., of San Diego, appointed Todd Myers chief financial officer and Siegfried Reich vice president, drug discovery.
Stem Cell Therapeutics Corp., of Calgary, Alberta, appointed Ian Brown to its board.
Targanta Therapeutics, of Indianapolis, appointed William Crouse to its board.